
QuidelOrtho Nabs LEX in $100M M&A
SAN DIEGO – Infectious disease diagnostic company QuidelOrtho (Nasdaq: QDEL) is refocusing its business strategy for molecular diagnostics following a new $100 million acquisition and the discontinuation of its Savanna PCR testing platform. Brian J. Blaser …